AU6841290A - Intravenous solutions for status epilepticus - Google Patents

Intravenous solutions for status epilepticus

Info

Publication number
AU6841290A
AU6841290A AU68412/90A AU6841290A AU6841290A AU 6841290 A AU6841290 A AU 6841290A AU 68412/90 A AU68412/90 A AU 68412/90A AU 6841290 A AU6841290 A AU 6841290A AU 6841290 A AU6841290 A AU 6841290A
Authority
AU
Australia
Prior art keywords
status epilepticus
intravenous solutions
intravenous
solutions
epilepticus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68412/90A
Inventor
Not Given Name
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU6841290A publication Critical patent/AU6841290A/en
Abandoned legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU68412/90A 1989-12-27 1990-12-21 Intravenous solutions for status epilepticus Abandoned AU6841290A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4653/89 1989-12-27
CH465389 1989-12-27

Publications (1)

Publication Number Publication Date
AU6841290A true AU6841290A (en) 1991-07-04

Family

ID=4280129

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68412/90A Abandoned AU6841290A (en) 1989-12-27 1990-12-21 Intravenous solutions for status epilepticus

Country Status (5)

Country Link
EP (1) EP0435826A1 (en)
AU (1) AU6841290A (en)
CA (1) CA2033118A1 (en)
IE (1) IE904685A1 (en)
PT (1) PT96307A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2702148B1 (en) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application of anti-convulsants in the treatment of neuro-AIDS.
FR2702151B1 (en) * 1993-06-03 1995-04-07 Rhone Poulenc Rorer Sa Application of anti-convulsants in the treatment of neuro-AIDS.
FR2713934B1 (en) * 1993-12-22 1996-01-12 Commissariat Energie Atomique Use of amino cyclodextrins for the aqueous solubilization of hydrophobic compounds, in particular of pharmaceutically active molecules.
US5466683A (en) * 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
GB9721497D0 (en) * 1997-10-09 1997-12-10 Ciba Geigy Ag Organic compounds
JP2001526194A (en) * 1997-12-19 2001-12-18 ターロ ファーマシューティカルズ ユーエスエイ インコーポレイテッド Topical carbamazepine formulations and methods of use
WO2003042182A1 (en) * 2001-11-12 2003-05-22 Novartis Ag Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain
GB0303615D0 (en) * 2003-02-17 2003-03-19 Novartis Ag Use of organic compounds
US20100143462A1 (en) * 2004-12-06 2010-06-10 Nutralease Ltd. New carbamazephine formulations having inproved solubility
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
WO2007007182A2 (en) * 2005-07-08 2007-01-18 Aurobindo Pharma Limited Solid and liquid dosage forms of an antiepileptic agent
GB0700773D0 (en) 2007-01-15 2007-02-21 Portela & Ca Sa Drug therapies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431641A (en) * 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action
US4596795A (en) * 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
DE3813015A1 (en) * 1988-04-19 1989-11-02 Desitin Arzneimittel Gmbh Stable, heat-sterilisable carbamazepine solution for parenteral administration

Also Published As

Publication number Publication date
PT96307A (en) 1991-09-30
CA2033118A1 (en) 1991-06-28
IE904685A1 (en) 1991-07-17
EP0435826A1 (en) 1991-07-03

Similar Documents

Publication Publication Date Title
AU5748990A (en) Venoscope
AU5348790A (en) Micro-multi-electrode arrangement
AU5874690A (en) Octreotide-pamoate
AU627080B2 (en) Sulphonylaminocarbonyltriazolinones
AU4848290A (en) Optical colour-splitter arrangement
AU6101190A (en) Soilresisting agent
AU5612790A (en) Hydroxypropylamines
AU6673290A (en) Dipyridodiazepines
AU5625390A (en) Novel compounds
AU5228290A (en) Novel compounds
AU5369290A (en) Excavator
AU631622B2 (en) Snow-vehicle
AU6841290A (en) Intravenous solutions for status epilepticus
AU6017390A (en) Novel compounds
AU623780B2 (en) Chromanderivate
AU6784290A (en) Novel compounds
AU5583190A (en) Compounds
AU6024690A (en) Microscope
AU6784390A (en) Novel compounds
AU5995790A (en) Embedded-in-optical-fiber type optical component
AU6627590A (en) Doll-container
AU5782590A (en) Thioxotetrazolines
AU5336690A (en) Leg-guard
AU6839190A (en) Triazolylsulfonamides
AU6268590A (en) Aminophosphinates